Chemoradiation induces upregulation of immunogenic cell death-related molecules together with increased expression of PD-L1 and galectin-9 in gastric cancer

Surgery alone or combined with chemo- and/or radiation therapy remains the primary treatment for gastric cancer (GC) to date and immunotherapeutic tools such as monoclonal antibodies are only slowly being implemented. This is partly due to the fact that the immune microenvironment in GC during chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Petersen, S. H., Kua, L. F., Nakajima, S., Yong, W. P., Kono, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192931/
https://www.ncbi.nlm.nih.gov/pubmed/34112882
http://dx.doi.org/10.1038/s41598-021-91603-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192931/
https://www.ncbi.nlm.nih.gov/pubmed/34112882
http://dx.doi.org/10.1038/s41598-021-91603-7

Ejemplares similares